Who is eligible for a 4th COVID-19 vaccine dose? A province-by-province breakdown - CBC.ca | Canada News Media
Connect with us

News

Who is eligible for a 4th COVID-19 vaccine dose? A province-by-province breakdown – CBC.ca

Published

 on


As a seventh wave of COVID-19 begins sweeping across Canada, with the Omicron BA.5 subvariant driving transmission, some provinces are expanding eligibility for a fourth dose of the vaccine.

The National Advisory Committee on Immunization (NACI) released its guidance for a fall booster campaign late last month. The federal advisory body recommended that those with increased risk of severe illness from COVID-19 should be offered a shot in the fall, adding that anyone between the ages of 12 and 64 may also be eligible at that time.

  • Have a coronavirus question or news tip for CBC News? Email ask@cbc.ca

Although all provinces are offering a fourth dose to eligible groups, as of June 19, just over half of Canadians have yet to receive their third dose, according to the Public Health Agency of Canada (PHAC).

“I would really double down on those efforts, in terms of getting fourth doses into the most vulnerable, and third doses into a lot of people who are still eligible but have not yet received them,” said Dr. Isaac Bogoch, an infectious disease specialist and physician with the University Health Network in Toronto.

While most provinces are already offering a fourth shot (or, for the general population, a second booster, as some immunocompromised individuals receive a third shot during their primary series) to their most vulnerable residents, some — such as Quebec and P.E.I. — have expanded eligibility substantially.

WATCH | Specialist says 3rd, 4th shots are important:

3rd and 4th COVID-19 shots both important right now, says expert

1 day ago
Duration 3:59

Infectious disease specialist Dr. Isaac Bogoch explains who benefits most from a fourth dose of COVID-19, but also stresses the need for many people to simply get a third shot.

“Those who would most benefit from a fourth dose are people on the older end of the spectrum and people with underlying medical conditions that put them at greater risk for severe infection,” Bogoch said, speaking specifically to the eligibility guidelines in July 2022.

“That’s what the data suggests,” he said. “So even if it’s opened up, just remember, that’s who would most benefit from a fourth dose.”

Below, CBC News has gathered eligibility guidelines from every province and territory.

The North and West Coast

Agnes Mills, 85, was the first person in the Yukon to receive the COVID-19 vaccine. Last week, the territorial government expanded eligibility for a fourth shot to those aged 18 and up. (Mark Kelly Photography/Government of Yukon)

Last week, the Yukon government expanded eligibility for a fourth shot.

All individuals 18 and older can now book a fourth shot if six months have passed since their third shot. Appointments begin on July 13. For those who have recently had COVID-19, a fourth shot (or second booster) is not recommended until three months have passed.

In the Northwest Territories, all individuals aged 50 and older and all immunocompromised people aged 12 and older are eligible to receive a fourth dose. In accordance with NACI’s guidelines, the territory recommends that individuals wait at least six months after their third dose before booking another shot.

Residents of Nunavut aged 18 and older are eligible for a fourth dose if it has been 4½ months since their last dose. Some jurisdictions are prioritizing specific age groups. 

In British Columbia, everyone aged 12 and up can receive a booster shot if six months have passed since their last dose, though those eligible are advised to wait until fall.

The province currently recommends a fourth dose for individuals aged 70 and older; people in long-term care or awaiting placement in long-term care; Indigenous people aged 55 and older; and all immunocompromised people.

The Prairies

A scene from a COVID-19 vaccination clinic in Thompson, Man. on Feb. 1, 2021. Among other groups, all Manitobans aged 50 and up are eligible for a fourth dose. (Tyson Koschik/CBC)

In Alberta, those 70 and up are eligible for a fourth dose; First Nations, Métis and Inuit people aged 65 and older; and all seniors living in congregate-care settings, regardless of age. 

According to the most recently available data from PHAC, 38 per cent of Alberta’s population has received a third dose. 

In Saskatchewan, all individuals 50 and over are eligible for a fourth dose if it’s been at least four months since they received their last shot.

Groups eligible for a fourth dose of the vaccine in Manitoba are individuals aged 50 and older; First Nations, Métis and Inuit people aged 30 and up; residents of personal care homes and elderly people living in congregate settings; and moderately to severely immunocompromised individuals aged 18 to 49.

Central Canada

The Vaccibus mobile clinic makes a stop at the University of Quebec in Outaouais in the first week of September 2021. Quebec has expanded eligibility for a fourth dose of the vaccine to all residents aged 18 and older. (Hugo Belanger/Radio-Canada)

As of July 14 in Ontario, all adults aged 18 to 59 who had a third shot at least five months ago (or three months since a COVID-19 infection) will be eligible for a fourth. Previously, the eligible groups were those aged 60 and older and First Nations, Métis and Inuit people who are 18 and older. 

According to public health officials, Quebec and Ontario entered the seventh wave of the pandemic last week, with the Omicron BA.5 subvariant dominating in both provinces.

Meanwhile, Quebec has expanded fourth-dose eligibility to all residents aged 18 and older, though a provincial spokesperson confirmed to CBC News that the province is prioritizing people 60 years and up, all individuals with underlying medical conditions, and anyone at a higher risk of complications from COVID-19. 

Atlantic Canada

A walk-in clinic is held at the Halifax Convention Centre. Nova Scotia’s current guidelines allow fourth doses for those aged 50 and older, if 168 days have passed since their last dose. (Robert Short/CBC)

The chief public health officer of Prince Edward Island announced last week that the province has expanded eligibility for a fourth shot to every resident aged 12 and up, as COVID-19 case numbers rise among Islanders.

Starting July 20 in Newfoundland and Labrador, anyone over 50 will be eligible for a fourth dose of the vaccine. Until then, those eligible are people aged 70 and older; all individuals living in a congregate setting for seniors; and Indigenous people or individuals living in a remote or isolated Indigenous community aged 18 and up.

WATCH | People over 50 eligible in N.L.:

N.L. offers 2nd COVID-19 booster to those over 50

4 hours ago
Duration 0:49

Newfoundland and Labrador is opening up eligibility for a second COVID-19 booster shot to anyone over 50, but the chief medical officer of health says there are many things to consider before getting another dose.

As of July 12, all residents of New Brunswick aged 18 and up are eligible for a fourth dose of the vaccine if it has been five months since their last shot. Chief medical officer of health, Dr. Jennifer Russell, announced the decision as hospitalizations rise across the province.

Nova Scotia’s current guidelines allow fourth doses for people aged 50 and older if 168 days have passed since their last dose.

For all residents of long-term care and senior congregate settings, members of First Nations communities who are 55 and older, and immunocompromised people aged 50 and older, the recommended interval between doses is 120 days.

  • Book here for an mRNA vaccine (Moderna, Pfizer). Book here for a non-mRNA vaccine (Janssen, Novavax). mRNA vaccines are recommended for most people in Canada.

Adblock test (Why?)



Source link

Continue Reading

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version